[Clinical evaluation of a new oral cephem, cefpodoxime proxetil in children]. 1989

H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
Department of Pediatrics, School of Medicine, Teikyo University.

Cefpodoxime proxetil (CPDX-PR, CS-807) was evaluated for its efficacy, safety and pharmacokinetics in children. CPDX-PR was effective in 93.6% of 47 cases with respiratory tract, middle ear, skin or urinary tract infections. Twice or 3 times daily administration of 3 mg/kg each was sufficient to treat streptococcal pharyngitis and Haemophilus influenzae infections. No severe adverse reaction was encountered in 52 cases treated with CPDX-PR. The serum half-life was approximately 2.17 +/- 0.24 hours after oral administration.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
November 1992, The Medical letter on drugs and therapeutics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
July 1989, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
July 1989, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
November 1993, The Annals of pharmacotherapy,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
April 1995, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
August 1990, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
November 1992, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
January 1994, The Japanese journal of antibiotics,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
January 1991, Drugs,
H Meguro, and O Arimasu, and H Shiraishi, and T Tajima, and F Hiruma, and S Nishimura, and N Sugie, and K Sugamata, and T Abe, and R Fujii
January 2019, Profiles of drug substances, excipients, and related methodology,
Copied contents to your clipboard!